CCL2 and coronary artery disorder: The results indicated that RFX1 was involved in regulating the recruitments of related epigenetic modification enzymes and histone modification status in the MCP1 promoter region in CD14+ monocytes, which further suggested that RFX1 may be a protective transcription factor for CAD.